GSK plc Transaction Notification

This filing reports a transaction by Dr. Hal Barron, a Non-Executive Director at GSK plc. The transaction involved the acquisition of 74 American Depositary Shares (ADS) with a total value of $49,670.00, occurring on May 15, 2026, at the New York Stock Exchange. This acquisition took place within Dr. Barron's GSK 401(k) plan account as a result of dividend reinvestment. The filing is an initial notification and is made on Form 6-K, indicating GSK plc is a foreign private issuer. The report is signed by Victoria Whyte, an authorized signatory for GSK plc, on May 20, 2026.